Monozygous twins with neuromuscular transmission defects at opposite sides of the motor endplate

Acta Neurologica Scandinavica

Volumn 119, Issue 3, 2009, Pages 207-211

  Punga, A R ^a   Nygren, I ^a   Askmark, H ^a   Stalberg E V ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Muscle disorders; Myasthenia gravis; Myopathies; Neurophysiology

Indexed keywords

3,4 DIAMINOPYRIDINE; ANTIBODY; AZATHIOPRINE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CHOLINERGIC RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL ANTIBODY;

ADULT; AREFLEXIA; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EATON LAMBERT SYNDROME; ELECTROMYOGRAPHY; EXERCISE TEST; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MONOZYGOTIC TWINS; MUSCLE ACTION POTENTIAL; MUSCLE BIOPSY; MUSCLE FATIGUE; MYASTHENIA; MYOSITIS; NERVE ENDING; NERVE STIMULATION; NEUROGRAPHY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR JUNCTION DISORDER; NEUROMUSCULAR TRANSMISSION; NOTE; PTOSIS;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; CALCIUM CHANNELS, P-TYPE; DISEASES IN TWINS; ELECTROMYOGRAPHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MOTOR ENDPLATE; MYOSITIS; NEUROMUSCULAR JUNCTION DISEASES; REFLEX, ABNORMAL; SYNAPTIC TRANSMISSION; TWINS, MONOZYGOTIC;

EID: 59249108534     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01082.x     Document Type: Note

References (10)

1. Lennon VA, Kryzer TJ, Griesmann GE et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995 332 : 1467 74.
2. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985 48 : 1246 52.
3. Evoli A, Tonali PA, Padua L et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003 126 : 2304 11.
4. Hoch W, McConville J, Helms S et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001 7 : 365 8.
5. Rostedt Punga A, Ahlqvist K, Bartoccioni E et al. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 2006 117 : 1434 43.
6. Sanders DB, El-Salem K, Massey JM et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 2003 60 : 1978 80.
7. Mossman S, Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986 1 : 116 9.
8. Engel AG, Ohno K, Sine SM. Congenital myasthenic syndromes: recent advances. Arch Neurol 1999 56 : 163 7.
9. Spreadbury I, Kishore U, Beeson D et al. Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation. J Neuroimmunol 2005 162 : 149 56.
10. Harper CM. Congenital myasthenic syndromes. Semin Neurol 2004 24 : 111 23.